XML 36 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of disaggregated revenue

The following table provides information about disaggregated revenue by product mix for the three and nine months ended September 30, 2018 and 2017:

 

    Three Months Ended
September30,
    Nine Months Ended
September 30,
 
    2018     2017     2018     2017  
Prescription vitamins   $ 3,261,459     $ 4,407,464     $ 10,797,861     $ 12,623,152  
IMVEXXY     212,076             212,076        
OTC products           10,134             30,343  
     Net revenue   $ 3,473,535     $ 4,417,598     $ 11,009,937     $ 12,653,495